Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score

Background: Triple fixed-dose combination (FDC) therapy is recommended in severe chronic obstructive pulmonary disease (COPD) patients experiencing frequent exacerbations and/or symptoms not controlled by dual FDCs. Since no randomized controlled trials (RCTs) have directly compared the different in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogliani, Paola, Ora, Josuel, Cavalli, Francesco, Cazzola, Mario, Calzetta, Luigino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369741/
https://www.ncbi.nlm.nih.gov/pubmed/35956108
http://dx.doi.org/10.3390/jcm11154491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369741/
https://www.ncbi.nlm.nih.gov/pubmed/35956108
http://dx.doi.org/10.3390/jcm11154491

Ejemplares similares